Considerations on the Off-label Use of Ketamine as a Treatment for Mood Disorders

Summary & key facts

This short opinion piece looks at using ketamine, a drug sometimes given in clinics, to treat mood problems like depression. The authors collect the main concerns from experts and suggest ways to reduce risks. They say ketamine can help some people quickly, but there are still big questions about safety, consistent clinic practices, and how to do more research before widespread use.

Key facts:

• This paper is a viewpoint. It does not report a new experiment. Instead, it sums up expert concerns about off-label ketamine use and offers suggestions for next steps.
• The authors note that ketamine can produce fast relief of mood symptoms for some people, but the long-term benefits and risks are still not well known.
• They raise safety concerns. These include the drug’s potential for misuse, possible physical harms with repeated use, and uncertainty about cognitive or bodily side effects over time.
• The paper highlights that clinics vary a lot in how they give ketamine. The authors suggest standardizing how patients are selected, how treatments are given, and how people are monitored afterward.
• A main recommendation is more careful research and better guidelines. The authors call for clear consent, close monitoring of patients, and studies that track outcomes and harms over longer periods.

Abstract

This Viewpoint summarizes a number of important issues related to the clinical use of ketamine for the treatment of psychiatric disorders addressed in the consensus statement and provides suggestions for addressing remaining concerns.

Topics

Anesthesia and Sedative Agents Electroconvulsive Therapy Studies Treatment of Major Depression

Categories

Health Sciences Medicine Pharmacology

Tags

Anxiety Intensive care medicine Ketamine Law Medicine MEDLINE Mood Mood disorders Political science Psychiatry Statement (logic)

Substances

Ketamine

Conditions & symptoms

Anxiety Sadness or low mood